Please login to the form below

Not currently logged in
Email:
Password:

Metrion Biosciences

This page shows the latest Metrion Biosciences news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: setback for Akcea/Ionis, Urovant adds gene therapy, Metrion gains funding

Daily Brief: setback for Akcea/Ionis, Urovant adds gene therapy, Metrion gains funding

Metrion awarded £637k for ion channel drug discovery. UK biotech and contract research firm Metrion Biosciences has been awarded £637, 000 under the Innovate UK Biomedical Catalyst Primer Award scheme.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Metrion Biosciences adds to its board Metrion Biosciences adds to its board

    Dr Barry Kenny and Dr Andrew Southan join the company. Metrion Biosciences, the specialist ion channel contract research and drug discovery group, has appointed Dr Barry Kenny and Dr Andrew Southan ... Dr Keith McCullagh, non-executive chairman of

  • Metrion Biosciences establishes scientific advisory board Metrion Biosciences establishes scientific advisory board

    Contract research organisation and drug discovery business Metrion Biosciences has established a scientific advisory board, which will provide strategic scientific guidance to the company. ... The board will also comprise of Professor Annette Dolphin,

  • Metrion Biosciences expands operations team Metrion Biosciences expands operations team

    Dr Andrew Southan appointed head of commercial operations. Cambridge, UK-based Metrion Biosciences has appointed Dr Andrew Southan as head of commercial operations. ... Dr Marc Rogers, chief scientific officer at Metrion Biosciences, said: “Since

  • Enterprise Therapeutics appoints CEO Enterprise Therapeutics appoints CEO

    Dr Ford also brings experience from Ario Pharma, where he is currently chief executive officer and co-founder, and Metrion Biosciences, where he serves as co-owner and investor director.

More from appointments
Approximately 3 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics